Timed walk as primary outcome measure of treatment response in clinical trials for HTLV-1-associated myelopathy: a feasibility study

Timed walk as primary outcome measure of treatment response in clinical trials for HTLV-1-associated myelopathy: a feasibility study

Bibliographic Details
Main Authors:	Martin, Fabiola, Inoue, Eisuke, Cortese, Irene C. M., de Almeida Kruschewsky, Ramon, Adonis, Adine, Grassi, Maria Fernanda Rios, Galvão-Castro, Bernardo, Jacobson, Steven, Yamano, Yoshihisa, Taylor, Graham P., Bland, Martin
Format:	Online
Language:	English
Published:	BioMed Central 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153909/

Similar Items

Change in timed walk as primary outcome measure of treatment response in HAMLET-P: HAM/TSP MuLticentre Efficacy trial-Prednisolone
by: Martin, Fabiola, et al.
Published: (2014)

Comparison of walking measures in patients with HTLV-1 Associated Myelopathy
by: Adonis, Adine, et al.
Published: (2015)

Assessing Walking Ability in People with HTLV-1-Associated Myelopathy Using the 10 Meter Timed Walk and the 6 Minute Walk Test
by: Adonis, Adine, et al.
Published: (2016)

Incidence of tropical spastic parapesis/ HTLV-1 associated myelopathy/ (TSP/HAM) in patients followed in a Reference center in Salvador, Brasil
by: Teixeira, Izabel Bou, et al.
Published: (2015)

Using the 6 minute walk to investigate endurance in patients with HTLV associated myelopathy
by: Adonis, A, et al.
Published: (2014)

Effect of Pulsed Methylprednisolone on Pain, in Patients with HTLV-1-Associated Myelopathy
by: Buell, Kevin G., et al.
Published: (2016)

Assessment of functional capacity and flexibility of patients infected with HTLV-1
by: Santos, Isabelle Rocha, et al.
Published: (2015)

A proof of concept study of Infliximab for the treatment of HTLV-1-associated myelopathy
by: Martin, Fabiola, et al.
Published: (2014)

Treatment of patients with HTLV-1-associated myelopathy with methotrexate
by: Ahmed, S, et al.
Published: (2014)

Quality of life (QOL) and depression in HTLV-1 carriers
by: Galvão-Phileto, Ana V, et al.
Published: (2011)

Ciclosporin A Proof of Concept Study in Patients with Active, Progressive HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis
by: Martin, Fabiola, et al.
Published: (2012)

CSF CXCL10, CXCL9, and Neopterin as Candidate Prognostic Biomarkers for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
by: Sato, Tomoo, et al.
Published: (2013)

Biomarker to predict treatment response in patients with HTLV-1 associated myelopathy/Tropical spastic paraparesis (HAM/TSP)
by: Tamaki, Keiko, et al.
Published: (2015)

HTLV-1 proviral load as an indicative marker of HAM/TSP: a systematic review of studies of patients with HAM/TSP
by: Bassi, Shiva Shaan, et al.
Published: (2014)

Susceptibility of Primary HTLV-1 Isolates from Patients with HTLV-1-Associated Myelopathy to Reverse Transcriptase Inhibitors
by: Macchi, Beatrice, et al.
Published: (2011)

CXCL10 and neopterin in CSF are candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis
by: Yamano, Yoshihisa, et al.
Published: (2014)

Human leukocyte antigen (HLA) class I frequencies in human T-cell lymphotropic virus type 1 (HTLV-1)-infected patients from Salvador-Brazil
by: Olavarria, Viviana N, et al.
Published: (2011)

Ascorbic Acid Has Superior Ex Vivo Antiproliferative, Cell Death-Inducing and Immunomodulatory Effects over IFN-α in HTLV-1-Associated Myelopathy
by: Moens, Britta, et al.
Published: (2012)

CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis
by: Menezes, Soraya Maria, et al.
Published: (2014)

An Evaluation of the Spontaneous Proliferation of Peripheral Blood Mononuclear Cells in HTLV-1-Infected Individuals Using Flow Cytometry
by: Pinto, Lorena Ana, et al.
Published: (2011)

Human T-Lymphotropic Virus Type 1 (HTLV-1) and Regulatory T Cells in HTLV-1-Associated Neuroinflammatory Disease
by: Araya, Natsumi, et al.
Published: (2011)

A case of post-transplant adult T-cell leukemia/lymphoma presenting myelopathy similar to but distinct from human T-cell leukemia virus type I (HTLV- I)-associated myelopathy
by: Kawamata, Toyotaka, et al.
Published: (2014)

Effect of pulsed methylprednisolone on disease severity, viral load and inflammation in patients with human T-lymphotropic virus type 1 associated myelopathy
by: Buell, Kevin, et al.
Published: (2015)

Nation-wide epidemiological study of Japanese patients with rare viral myelopathy using novel registration system (HAM-net)
by: Coler-Reilly, Ariella L. G., et al.
Published: (2016)

Proteomic profiling of HTLV-1 infected T-cells for the identification of potential biomarkers and therapeutic targets for HTLV-1 associated myelopathy/ tropical spastic paraparesis and adult T-cell leukemia
by: Ueda, Koji, et al.
Published: (2011)

Clinical Pathophysiology of Human T-Lymphotropic Virus-Type 1-Associated Myelopathy/Tropical Spastic Paraparesis
by: Yamano, Yoshihisa, et al.
Published: (2012)

HTLV-1 proviral load of HAM/TSP patients according to new diagnostic criteria of HAM/TSP
by: Grassi, Maria F R, et al.
Published: (2011)

Deep sequencing analysis of Human T cell lymphotropic virus type 1 (HTLV-1) long terminal repeat (LTR) region of tropical spastic paraparesis (TSP)/HTLV-1 associated myelopathy (HAM) and asymptomatic carriers
by: Rego, Filipe FA, et al.
Published: (2014)

Seroprevalence of HTLV‐1 and HTLV‐2 amongst mothers and children in Malawi within the context of a systematic review and meta‐analysis of HTLV seroprevalence in Africa
by: Fox, James M., et al.
Published: (2016)

Human T lymphotropic virus type 1 (HTLV-1) proviral load induces activation of T-lymphocytes in asymptomatic carriers
by: Coutinho, Raimundo, et al.
Published: (2014)

Nation-wide epidemiological study in Japan on HTLV-1 associated myelopathy/tropical spastic paraparesis using HAM-net, a novel patient registration system
by: Coler-Reilly, Ariella LG, et al.
Published: (2014)

The plasticity of HTLV-1 infected CD4+CD25+CCR4+ T-cells through HTLV-1 tax in HAM/TSP
by: Araya, Natsumi, et al.
Published: (2011)

Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis
by: Kirk, Paul DW, et al.
Published: (2011)

Three plasma biomarkers of HTLV-1-associated myelopathy/tropical spastic paraparesis
by: Kirk, Paul, et al.
Published: (2011)

Aquaporin-4 Antibodies Are Not Related to HTLV-1 Associated Myelopathy
by: von Glehn, Felipe, et al.
Published: (2012)

Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
by: Nozuma, Satoshi, et al.
Published: (2014)

Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathy
by: Perzova, Raisa, et al.
Published: (2013)

Median Nerve Somatosensory Evoked Potential in HTLV-I Associated Myelopathy
by: Reza Boostani, et al.
Published: (2016-05-01)

Correction: Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
by: Nozuma, Satoshi, et al.
Published: (2016)

Median Nerve Somatosensory Evoked Potential in HTLV-I Associated Myelopathy
by: Boostani, Reza, et al.
Published: (2016)